Echa publishes REACH data on 15,000 chemicals
Echa has published information on approximately 15,000 substances registered under REACH.
The information, which comes from manufacturers and importers, includes details of each substance’s properties and its impacts on human health and the environment.
Regulatory authorities, businesses and researchers can use the data to improve safe use of chemicals, help reduce animal testing and boost innovation, the agency says.
Members of the public can also access and download data, it says, but because it is structured in an Iuclid 6 database, they might not find it easy to follow. Instead, it recommends they use the ‘information on chemicals’ portal on Echa’s website.
Echa says to respect the ownership rights of registrants, only select data can be downloaded. This is limited to:
• results from studies conducted by companies, but not the full summary; and
• information that is not claimed as confidential in the registration dossier.
Echa says that 2% of all dossiers have a confidentiality claim, but this does not mean that the entire dossiers are not published – only those limited elements that are claimed are not published.
In the agency's press release, Cefic director general Marco Mensink says it is important that Echa has published the REACH registration data “without jeopardising data ownership”.
With the available data, he says, a better understanding of toxicology can be developed “which will help to further reduce animal testing. It is a win-win for all stakeholders”.
Echa executive director Geert Dancet says making the data downloadable, in a format that can be reused by others, is “another step towards safer chemicals in Europe”.
Industry can use the data to improve the way in which it uses chemicals – by enhancing safety data sheets and the classification and labelling of substances and products, Echa says.
The press release also quotes Jerker Ligthart of NGO ChemSec as saying such information is a step towards chemical transparency which "will allow for better in-depth analysis of groups of chemicals instead of the substance-by-substance approach”.
He adds that making the data public could mean “faster and earlier” identification of substances of concern which companies can substitute, and will also help companies make better informed decisions during product development.
Registered users can download the data and the Iuclid 6 application from the Iuclid website, free of charge. The same set of data is used to provide input to the OECD’s eChemPortal, Qsar Toolbox and Cefic’s AMBIT project.
2026-10-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
UK Opens Formal Review of AkzoNobel–Axalta $25 Billion Merger
-
U.S. Congress Passes Bill Authorizing Tariffs of Up to 100% on Major Buyers of Russian Energy
-
U.S. Formally Imposes Antidumping and Countervailing Duty Orders on Chinese L-Lysine
-
U.S. and China Open New High-Level Trade Talks on Tariffs, Critical Minerals and Pharma Investment
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
3M, DuPont and Honeywell Must Face Firefighters’ PFAS Turnout-Gear Lawsuit
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
Recommend Reading
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
FDA Warning Letters Put GMP Back in Focus
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
DMF Market Consumption Slows Down, Prices Trade in a Narrow Range
-
Fundamentals Strengthen, Butadiene Market Rises in China
-
Demand Continues to Surge, Prices Break Through and Rise
-
Both Supply and Demand Weak, Toluene Market Experiences Volatile Decline
-
Supply Contraction Keeps Raw Materials Firm; PP Market Prices Remain High and Continue to Rise